Effects of SGLT-2 Inhibitors on Plasma Concentrations and Renal Clearance of the Risk Marker Trimethylamine-N-Oxide in Patients With Type-2 Diabetes. [PDF]
Zimmer KB +6 more
europepmc +1 more source
Trimethylamine N-Oxide and Impaired Spermatogenesis in the Gut-Testis Axis: A Focused Review of Current Evidence. [PDF]
Zhang X +6 more
europepmc +1 more source
Trimethylamine N-oxide and major adverse cardiac and cerebrovascular events: results of umbrella review and meta-analysis. [PDF]
Obeid R +6 more
europepmc +1 more source
Trimethylamine N-oxide as a key microbial mediator in the progression of diabetic kidney disease. [PDF]
Kashiv P +4 more
europepmc +1 more source
Trimethylamine N-Oxide and mortality in hemodialysis patients: like a mystery
Yu Zhao, Wenyun Wang, Zhilong Dong
doaj +1 more source
Trimethylamine N-Oxide Combined with Phenylacetylglutamine as Potential Biomarkers for Diabetic Kidney Disease. [PDF]
Xiong G +13 more
europepmc +1 more source
Trimethylamine-N-oxide: the microbial cue in immune-mediated disorders. [PDF]
Mirji G, Bhat SA, Shinde RS.
europepmc +1 more source
Membrane Raft Redox Signaling Mediates Trimethylamine N-Oxide-Induced NLRP3 Inflammasome Activation and Endothelial Dysfunction. [PDF]
Haque MA +6 more
europepmc +1 more source
Gut microbiota-derived trimethylamine N-oxide and the incidence and recurrence of atrial fibrillation: a systematic review and meta-analysis. [PDF]
Dong J, Chen L, Zheng N, Yang M.
europepmc +1 more source
[Correlation between trimethylamine-N-oxide and cardiovascular metabolic markers]. [PDF]
Zhang H +18 more
europepmc +1 more source

